Asthma is a serious lung disease that affects nearly 20 million people in the
United Sates and 250 million people worldwide. Airway hyperresponsiveness (AHR) and
airway remodeling are cardinal characteristics of asthma. It is known that airway smooth
muscle contraction plays a critical role in mediating AHR whereas airway smooth muscle
cell proliferation largely contributes to the pathogenesis of airway remodeling. However,
the mechanisms that regulate airway smooth muscle contraction and growth are not well
understood. Polo-like kinase 1 (Plk1) is a serine/threonine protein kinase that has been
implicated mitosis of nonmuscle cells. The functional role of Plk1 in smooth muscle is
currently unknown. Our pilot studies have shown that Plk1 is involved in the regulation of
airway smooth muscle contraction and cytokinesis, a key step of cell proliferation. The
major goal of the project is to unveil the role of Plk1 in airway smooth muscle contraction
and cytokinesis in vitro, and the pathogenesis of AHR and airway remodeling in vivo. In
Aims 1 and 2, the role and mechanisms of Plk1 in airway smooth muscle contraction and
cytokinesis will be characterized. In Aim 3, the role of Plk1 in allergen-induced AHR,
airway remodeling and airway inflammation will be assessed using animal models of
asthma. Completion of these studies should advance our knowledge regarding smooth
muscle contraction/cytokinesis and asthma pathology. Obtaining this knowledge may
identify Plk1 as a new biological target for the development of new therapy to treat
asthma.
Public Health Relevance Statement
Allergic asthma is characterized by airway hyperresponsiveness and airway
remodeling, which stems from abnormal airway smooth muscle contraction and
proliferation. However, the cellular and molecular mechanisms that regulate
smooth muscle contraction and growth are not well elucidated. This project is to
reveal previously unknown mechanisms that control airway smooth muscle
contraction and proliferation in vitro and asthma pathology in vivo using the state-
of-the art technology. Obtaining this knowledge is essential for the development
of new strategies to treat the disease.
No Sub Projects information available for 5R01HL130304-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HL130304-02
Patents
No Patents information available for 5R01HL130304-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HL130304-02
Clinical Studies
No Clinical Studies information available for 5R01HL130304-02
News and More
Related News Releases
No news release information available for 5R01HL130304-02
History
No Historical information available for 5R01HL130304-02
Similar Projects
No Similar Projects information available for 5R01HL130304-02